Physician profile
Heather Olson
NPI 1952723702
$2,811.40
in general payments reported to CMS, 2019-2025
22 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $683 · 2022: $666 · 2023: $365 · 2024: $497 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $489.18 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astellas Pharma US INC | $396.84 | 2021-2025 | Veozah, Myrbetriq |
| Amgen INC. | $329.22 | 2021-2025 | Evenity, Prolia, Prolia |
| Novo Nordisk INC | $302.77 | 2021-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $243.52 | 2021-2023 | Xarelto |
| Abbvie INC. | $182.04 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $173.26 | 2021-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $142.62 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.32 | 2022-2025 | Jardiance, Ofev |
| Exact Sciences Corporation | $91.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $62.09 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $45.91 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $36.91 | 2021 | |
| Ethicon US, LLC | $31.80 | 2025 | Stratafix |
| E.R. Squibb & Sons, L.L.C. | $30.07 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.91 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.84 | 2025 | |
| Merck Sharp & Dohme LLC | $19.63 | 2021 | |
| Edwards Lifesciences Corporation | $16.33 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $16.25 | 2025 | Opsumit, Uptravi |
| Medtronic, INC. | $15.01 | 2025 | Minimed 780g |
| Pfizer INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.